Sarah S Jaser1, Lori C Jordan2,3,4. 1. Department of Pediatrics, Vanderbilt University Medical Center, 2525 West End Ave., Suite 1200, Nashville, TN, 37203, USA. sarah.jaser@vumc.org. 2. Department of Pediatrics, Vanderbilt University Medical Center, 2525 West End Ave., Suite 1200, Nashville, TN, 37203, USA. 3. Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA. 4. Department of Radiology and Radiological Science, Vanderbilt University Medical Center, Nashville, TN, USA.
Abstract
PURPOSE OF REVIEW: To synthesize findings from studies of neurocognitive complications in children with type 1 diabetes (T1D) and highlight potential risk and protective factors. RECENT FINDINGS: Emerging evidence suggests that hyperglycemia and time in range may be more important for brain development than episodes of hypoglycemia. Further, diabetic ketoacidosis (DKA) at the time of T1D diagnosis appears to be a particular risk factor for neurocognitive complications, particularly deficits in executive function skills and memory, with differences in cerebral white matter microstructure seen via advanced magnetic resonance imaging methods, and lower scores on measures of attention and memory observed among children who were diagnosed in DKA. Other factors that may influence neurocognitive development include child sleep, caregiver distress, and diabetes device use, presumably due to improved glycemic control. We highlight neurocognitive risk and protective factors for children with T1D and priorities for future research in this high-risk population.
PURPOSE OF REVIEW: To synthesize findings from studies of neurocognitive complications in children with type 1 diabetes (T1D) and highlight potential risk and protective factors. RECENT FINDINGS: Emerging evidence suggests that hyperglycemia and time in range may be more important for brain development than episodes of hypoglycemia. Further, diabetic ketoacidosis (DKA) at the time of T1D diagnosis appears to be a particular risk factor for neurocognitive complications, particularly deficits in executive function skills and memory, with differences in cerebral white matter microstructure seen via advanced magnetic resonance imaging methods, and lower scores on measures of attention and memory observed among children who were diagnosed in DKA. Other factors that may influence neurocognitive development include child sleep, caregiver distress, and diabetes device use, presumably due to improved glycemic control. We highlight neurocognitive risk and protective factors for children with T1D and priorities for future research in this high-risk population.
Entities:
Keywords:
Child; Cognition; Neuroimaging; Type 1 diabetes
Authors: Janet Silverstein; Georgeanna Klingensmith; Kenneth Copeland; Leslie Plotnick; Francine Kaufman; Lori Laffel; Larry Deeb; Margaret Grey; Barbara Anderson; Lea Ann Holzmeister; Nathaniel Clark Journal: Diabetes Care Date: 2005-01 Impact factor: 19.112
Authors: Yana Suchy; Sara L Turner; Tara L Queen; Kara Durracio; Deborah J Wiebe; Jonathan Butner; Emilie I Franchow; Perrin C White; Mary A Murray; Michael Swinyard; Cynthia A Berg Journal: Health Psychol Date: 2016-05-12 Impact factor: 4.267
Authors: Esther Donga; Marieke van Dijk; J Gert van Dijk; Nienke R Biermasz; Gert-Jan Lammers; Klaas van Kralingen; Roel P L M Hoogma; Eleonora P M Corssmit; Johannes A Romijn Journal: Diabetes Care Date: 2010-03-31 Impact factor: 17.152
Authors: Paul K Mazaika; Stuart A Weinzimer; Nelly Mauras; Bruce Buckingham; Neil H White; Eva Tsalikian; Tamara Hershey; Allison Cato; Tandy Aye; Larry Fox; Darrell M Wilson; Michael J Tansey; William Tamborlane; Daniel Peng; Mira Raman; Matthew Marzelli; Allan L Reiss Journal: Diabetes Date: 2015-10-28 Impact factor: 9.337
Authors: Allan L Reiss; Booil Jo; Ana Maria Arbelaez; Eva Tsalikian; Bruce Buckingham; Stuart A Weinzimer; Larry A Fox; Allison Cato; Neil H White; Michael Tansey; Tandy Aye; William Tamborlane; Kimberly Englert; John Lum; Paul Mazaika; Lara Foland-Ross; Matthew Marzelli; Nelly Mauras Journal: Nat Commun Date: 2022-08-30 Impact factor: 17.694
Authors: Arcelia Arrieta; Tadej Battelino; Andrea E Scaramuzza; Julien Da Silva; Javier Castañeda; Toni L Cordero; John Shin; Ohad Cohen Journal: Diabetes Obes Metab Date: 2022-05-12 Impact factor: 6.408